Related Experiment Video
Updated: Feb 28, 2026
Author Spotlight: Validating Cancer Therapy Responses with Desmoplastic Spheroid Models
Published on: September 27, 2024
The pancreatic cancer microenvironment: A true double agent
Laleh G Melstrom1, Marcela D Salazar2, Don J Diamond2
1Department of Surgery and Experimental Therapeutics, City of Hope National Medical Center, Duarte, California.
Abstract:
The tumor microenvironment in pancreatic cancer is a complex balance of pro- and anti-tumor components. The dense desmoplasia consists of immune cells, extracellular matrix, growth factors, cytokines, and cancer associated fibroblasts (CAF) or pancreatic stellate cells (PSC). There are a multitude of targets including hyaluronan, angiogenesis, focal adhesion kinase (FAK), connective tissue growth factor (CTGF), CD40, chemokine (C-X-C motif) receptor 4 (CXCR-4), immunotherapy, and Vitamin D. The developing clinical therapeutics will be reviewed.
Insights
Pancreatic cancer's tumor microenvironment is complex, featuring dense desmoplasia. Emerging therapies target key components like cancer-associated fibroblasts and immune cells to combat this challenging disease.
Area of Science:
- Oncology
- Cancer Biology
- Tumor Microenvironment Research
Background:
- Pancreatic cancer is characterized by a dense, immunosuppressive tumor microenvironment (TME).
- This TME includes extracellular matrix, immune cells, growth factors, and pancreatic stellate cells (PSCs), also known as cancer-associated fibroblasts (CAFs).
- The complex interplay of these components promotes tumor growth and resistance to therapy.
Purpose of the Study:
- To review the multifaceted nature of the pancreatic cancer tumor microenvironment.
- To identify and discuss key molecular targets within the TME.
- To provide an overview of developing clinical therapeutics targeting these components.
Main Methods:
- Literature review of pancreatic cancer TME research.
- Analysis of key molecular targets and signaling pathways.
- Survey of current and emerging clinical therapeutic strategies.
Main Results:
- The TME comprises numerous pro- and anti-tumorigenic elements, including hyaluronan, angiogenesis factors, focal adhesion kinase (FAK), connective tissue growth factor (CTGF), CD40, CXCR-4, and Vitamin D.
- Pancreatic stellate cells (PSCs) are crucial components of the desmoplastic stroma.
- Various therapeutic strategies are under investigation to modulate the TME.
Conclusions:
- Targeting the complex pancreatic cancer TME is essential for therapeutic advancement.
- Modulating components like CAFs, immune cells, and specific molecular pathways holds promise.
- Further clinical development of novel therapeutics is critical for improving patient outcomes.
